Publication | Closed Access

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseEarly Coronary RevascularisationGusto Iv-acsPharmacotherapyAcute Myocardial InfarctionPublic HealthMedicineCardiologyAcute Coronary SyndromesEmergency MedicineCoronary Artery DiseaseMyocardial Infarction